<?xml version="1.0" encoding="UTF-8"?>
<p id="para0013">Chen et al. noted that “disorders of consciousness” (e.g., hypoxic encephalopathy) were more frequent in patients who succumbed to the COVID-19 than patients who went on to survive the infection (20% versus 1%, respectively).
 <xref rid="bib0010" ref-type="bibr">
  <sup>10</sup>
 </xref> And, similar to the patients described in this brief report, a New York Times article citing physicians caring for COVID-19 patients also described patients presenting with confusion and AMS prior to developing a fever or respiratory illness.
 <xref rid="bib0011" ref-type="bibr">
  <sup>11</sup>
 </xref> The article also references findings from physicians in Wuhan China who collected data on neurological findings in 214 patients hospitalized for SARS-CoV-2 infection.
 <xref rid="bib0012" ref-type="bibr">
  <sup>12</sup>
 </xref> These physicians found that 36.4% of patients had neurological findings ranging from impaired consciousness and skeletal muscle injury (as assessed by myalgia and an elevated creatinine phosphokinase) to cerebrovascular disease (e.g., ischemic stroke and cerebral hemorrhage).
</p>
